TY - JOUR
T1 - Secondary prevention therapy in patients with coronary artery disease
AU - Dhond, Milind
AU - Amsterdam, Ezra A
PY - 1998/1
Y1 - 1998/1
N2 - Recent therapeutic advances have reduced cardiac morbidity and mortality in patients with clinically documented coronary artery disease (CAD). This secondary prevention approach (as opposed to the primary prevention approach to avert the emergence of clinical cardiac disease in healthy individuals) encompasses three broad categories: coronary risk factor modification (eg, control of hypercholesterolemia, hypertension, body weight, and smoking through lifestyle changes and drug therapy), use of cardioprotective drugs (eg, aspirin, beta blockers, ACE inhibitors), and myocardial revascularization. Until recently, therapy has focused on revascularization, despite its high cost. However, recent studies showing the efficacy of risk factor modification and cardioprotective drugs, combined with economic concerns, have increased the emphasis on these modalities for secondary prevention of coronary events.
AB - Recent therapeutic advances have reduced cardiac morbidity and mortality in patients with clinically documented coronary artery disease (CAD). This secondary prevention approach (as opposed to the primary prevention approach to avert the emergence of clinical cardiac disease in healthy individuals) encompasses three broad categories: coronary risk factor modification (eg, control of hypercholesterolemia, hypertension, body weight, and smoking through lifestyle changes and drug therapy), use of cardioprotective drugs (eg, aspirin, beta blockers, ACE inhibitors), and myocardial revascularization. Until recently, therapy has focused on revascularization, despite its high cost. However, recent studies showing the efficacy of risk factor modification and cardioprotective drugs, combined with economic concerns, have increased the emphasis on these modalities for secondary prevention of coronary events.
UR - http://www.scopus.com/inward/record.url?scp=1842761646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842761646&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:1842761646
VL - 33
SP - 120
EP - 136
JO - Formulary
JF - Formulary
SN - 1082-801X
IS - 1
ER -